Compare INVA & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INVA | REX |
|---|---|---|
| Founded | 1996 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2000 | 1994 |
| Metric | INVA | REX |
|---|---|---|
| Price | $20.62 | $44.31 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 628.4K | 144.2K |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 2.22 | 0.56 |
| Revenue | $217,217,000.00 | ★ $650,487,000.00 |
| Revenue This Year | $8.95 | $19.45 |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | ★ $9.40 | $79.36 |
| Revenue Growth | ★ 62.63 | 1.24 |
| 52 Week Low | $16.52 | $30.02 |
| 52 Week High | $25.15 | $64.95 |
| Indicator | INVA | REX |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 47.39 |
| Support Level | $19.15 | $41.90 |
| Resistance Level | $22.86 | $48.91 |
| Average True Range (ATR) | 0.46 | 1.48 |
| MACD | -0.07 | -0.13 |
| Stochastic Oscillator | 4.57 | 41.66 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
REX American Resources Corp operates as a holding company that engages in investments in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include Ethanol, dried distillers grains, modified distillers grains, Distillers corn oil, Modified distillers grains, and Other.